BioSpace News Archive

Albany NY, United States: Transparency Market Research has published a new report on the working dynamics of the global voice prosthesis devices market in which the report expects the market to exhibit a CAGR of 4.5% for the period of forecast of 2018 2026.

Bavarian Nordic A/S announced that the Company has secured a contract with an undisclosed European country to supply its IMVANEX® smallpox vaccine in response to new cases of monkeypox evolving during May 2022.

Better Therapeutics, Inc today announced a virtual educational webinar symposium featuring a panel of medical and technology experts to discuss the use of nCBT delivered via prescription digital therapeutics to combat the underlying causes of cardiometabolic diseases like type 2 diabetes.

Helsinn Group is pleased to announce the appointment of Dr Melanie Rolli as Group Chief Operating Officer, effective June 1, 2022.

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with IVL led to excellent long-term outcomes out to two years with preservation of future treatment options.

Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the H.C. Wainwright Global Hybrid Investment Conference.

Science Translational Medicine has published the results of a Duke University-led preclinical hamster transmission study that found that Vaxart’s (NASDAQ: VXRT) S-only oral COVID-19 vaccine candidate inhibited the transmission of SARS-CoV-2.

Allogene Therapeutics Announces Oral Presentation of Pre-Clinical Data Highlighting Improved Anti-Tumor Activity of Donor-Derived Allogeneic CAR T Cells at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting.

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler , Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Global Investment Conference.

To support the Greater Boston biotech ecosystem, Thermo Fisher Scientific is joining forces with biotech incubator LabShares Newton to provide instruments, lab equipment and consumables to help early-stage life sciences companies accelerate their